Can Weight Loss Drugs Help Lower Depression and Anxiety Risk?

One of the weight loss drugs to treat obesity and type 2 diabetes is called GLP-1 agonists. These drugs, such as Ozempic, Wegovy, and Mounjaro, can help people lose weight and improve their blood sugar levels.

But do they also have an impact on mental health? Research has shown a clear link between obesity and mental health disorders. Studies consistently demonstrate that obesity can increase the risk of developing depression and anxiety, while these mental health issues can also contribute to weight gain and obesity.

Recent research suggests that GLP-1 agonists may also help lower the risk of depression and anxiety. These are two common mental disorders that affect millions of people worldwide.

In this post, we’ll explore if certain weight loss medications may help reduce depression and anxiety risk.

A Closer Look At The Research Findings

There have been several research studies that have explored the possible link between GLP-1 drugs with depression and anxiety. Here are some of the main findings:

The American Journal Of Geriatric Psychiatry states that a meta-analysis of randomized controlled trials showed that GLP-1 receptor agonists (GLP-1RAs) were effective in reducing depression and anxiety symptoms in patients with type 2 diabetes, in comparison to a placebo.

This study found that people with diabetes who took Tirzepatide were 65% less likely to have depression. Also, 60% less likely to have anxiety compared to those not taking GLP-1 weight loss drugs. Similarly, people with diabetes taking Semaglutide were 45% less likely to have depression and 44% less likely to have anxiety.

GLP-1RAs have been shown to increase serotonin, dopamine, and norepinephrine levels in the brain, which are important for mood regulation. They may also interact with hormones and peptides affecting mood and behavior, such as cortisol, oxytocin, and ghrelin.

So, when diabetic patients take medications like Tirzepatide, Semaglutide, Dulaglutide, or Exenatide, which are GLP-1 receptor agonists, they are less likely to be diagnosed with depression after starting the medication compared to those who don’t take these medications.

A review article published in 2020 suggested that GLP-1RAs may have antidepressant effects by modulating various processes related to neuroprotection, inflammation, stress response, energy metabolism, gut-brain crosstalk, and the stability of the gut.

How Do GLP-1 Drugs Like Ozempic May Target Anxiety And Depression?

Some drugs that help people lose weight and control their blood sugar may also make them feel less sad and worried. These drugs are called GLP-1 drugs, and some of them are Ozempic or Semaglutide and Tirzepatide.

Some experts think that these drugs make people happier because they lose weight and feel better about themselves. Others think these drugs affect the brain directly and help it work better.

Here are some more details about how GLP-1 drugs can help with anxiety and depression:

1. Reduces Inflammation: Inflammation is a natural response of the immune system to fight infections and injuries. But, sometimes, it can become chronic and harmful. Chronic inflammation can damage the brain cells and affect their function, leading to mood disorders such as depression symptoms. 

GLP-1  weight loss drugs can lower the levels of inflammatory molecules in the brain and protect the brain cells from damage.

2. Balances Serotonin: GLP-1 drugs can also help improve the balance of neurotransmitters in the brain, like serotonin. Serotonin is a chemical messenger that regulates mood, appetite, sleep, and other functions. Low levels of serotonin can cause depression and anxiety. 

GLP-1 drugs can increase the production and release of serotonin in the brain and enhance its effects on the receptors. It can improve the mood and reduce the anxiety of the users.

3. Stimulates Neurogenesis In The Brain: Neurogenesis is important for learning, memory, and emotional regulation. It can also help the brain recover from stress and trauma. Depression and anxiety can impair neurogenesis and cause cognitive and emotional problems. 

GLP-1 drugs can promote neurogenesis in the brain, especially in the hippocampus, a key area for mood and memory. This can enhance the brain function and resilience of the users.

These are some of the possible ways that GLP-1 drugs can help with anxiety and depression by affecting the brain directly. However, there is a need to do more research and fully understand these mechanisms to confirm the causal relationship and the clinical implications.

Can Losing Weight Impact Mental Health?

Experts suggest that losing fat using weight loss drugs can lead to changes in social interactions and physical health, affecting mental health.

First, obesity has a connection with inflammation, which can negatively affect brain function. Second, people with obesity often face discrimination and stigma, which can contribute to mental health issues like anxiety and depression.

Moreover, obesity may cause individuals to feel isolated, which can worsen their mood. Difficulty with physical activity due to obesity can also lead to increased feelings of depression and anxiety.

Depression itself can lead to unhealthy eating habits, such as emotional eating or relying on fast food, due to low energy levels. However, intentional weight loss can improve mood, possibly because it can ease conditions associated with obesity, like chronic pain and poor mobility.

Feeling more in control of one’s health can also positively impact mood. While researchers believe weight loss medications could potentially address both weight loss and mental health issues like anxiety and depression, they need more research to confirm this.

Controlled trials are necessary to understand whether these medications directly impact mood or if the effects are mainly through weight loss.

Additionally, factors like a balanced diet, exercise, and accurate diagnosis of depression need to be considered in future studies. It’s also important to note that symptoms of depression can overlap with those of obesity or diabetes, making diagnosis more complex.

Conclusion

A recent preliminary review by the Food and Drug Administration found no evidence linking GLP-1s to suicidal thoughts or actions compared with those taking earlier versions of weight loss drugs.

So, GLP-1 medications, like Ozempic,  might help with depression and anxiety, but we need more research to be sure they’re safe and effective for these issues. If you’re thinking about using GLP-1 meds for mood problems, talk to your doctor first. They can help you decide if it’s right for you.

Contact Us Today

Get in touch with our expert team at Fitelo to kick-start your transformative journey! Let us guide you toward your weight loss goals and help you cultivate sustainable and healthy eating habits. So, contact us today and take the first step towards a healthier, happier you with Fitelo!

Disclaimer

This article was written to help you make healthy and better food choices. So, be aware and take care. The vital thing to consider is your health before starting a restrictive diet. Therefore, before starting, always seek advice from a doctor/dietitian if you have any concerns.

Eat Healthy, Live Healthy. Enjoy a long, happy life.